CELL AND GENE THERAPY INSIGHTS

Actionable insights for overcoming CMC challenges in TIL therapy: GRIT’s strategic approach

Actionable insights for overcoming CMC challenges in TIL therapy: GRIT’s strategic approach

Alex Lei
19 June 2025
Register
Optimizing plasmid DNA purification: strategies for reliable and expandable processes

Optimizing plasmid DNA purification: strategies for reliable and expandable processes

Christy Franco, Jasmina Puc
17 June 2025
Register
Non-viral GMP manufacturing for engineered cells at clinical and commercial scale

Non-viral GMP manufacturing for engineered cells at clinical and commercial scale

Leif Anderson, Chris Abraham
12 June 2025
Register
Optimizing for faster quality control in cell therapies: leveraging rapid detection methods

Optimizing for faster quality control in cell therapies: leveraging rapid detection methods

Srinath Kashi Ranganath
05 June 2025
Register
To 1000L and beyond: streamlining AAV manufacturing with transfection complex stabilization

To 1000L and beyond: streamlining AAV manufacturing with transfection complex stabilization

Leisha Kopp
03 June 2025
Register
Navigating the transition from research to clinical-scale cell therapy manufacture

Navigating the transition from research to clinical-scale cell therapy manufacture

Steven Feldman, Johannes Fruehauf, Mary Ann Santos
22 May 2025
Register
A case study in faster, higher-quality pDNA manufacturing

A case study in faster, higher-quality pDNA manufacturing

Xiangming Gu, Lucas Smith
20 May 2025
Register
Next-gen immunotherapy: a guide for CGT developers

Next-gen immunotherapy: a guide for CGT developers

Alex Sargent
09 May 2025
EBook
Essential equipment for advancing cell and gene therapy: innovations in incubation, monitoring, and cold storage

Essential equipment for advancing cell and gene therapy: innovations in incubation, monitoring, and cold storage

Tia Harmon
07 May 2025
FastFacts
Exploring strategies for scaling up allogeneic natural killer cell therapy

Exploring strategies for scaling up allogeneic natural killer cell therapy

Will Rosellini
02 May 2025
Interview
Flow with confidence: innovations that foster flexibility and scale in closed-system manufacturing

Flow with confidence: innovations that foster flexibility and scale in closed-system manufacturing

Nik Ekman
01 May 2025
Watch
The path to PAT: the role of process analytical technologies in advancing CAR-T therapy production

The path to PAT: the role of process analytical technologies in advancing CAR-T therapy production

Sarah Rajani
01 May 2025
Interview
Next-gen cell therapy manufacturing: leveraging flexibility and automation for success

Next-gen cell therapy manufacturing: leveraging flexibility and automation for success

David Shaw, Fred Parietti, Carl Dargitz
01 May 2025
Innovator Insight
Digitalization and data analytics: shaping the future of cell bioprocessing

Digitalization and data analytics: shaping the future of cell bioprocessing

Mohamed Noor
01 May 2025
Interview
Safety assays for quality control of ATMPs: improved mycoplasma detection for cell-based biotherapeutics

Safety assays for quality control of ATMPs: improved mycoplasma detection for cell-based biotherapeutics

Jens Björkman, Andreas Hecker
30 April 2025
Watch
Manufacturing Quality Control for Plasmid DNA Critical Starting Materials

Manufacturing Quality Control for Plasmid DNA Critical Starting Materials

A Frazer, L R. Salvitti, S Lovatt et al
29 April 2025
Watch
Optimizing iPSC therapies: strategies for safe, cost-effective, and scalable manufacturing

Optimizing iPSC therapies: strategies for safe, cost-effective, and scalable manufacturing

K Bruce, K Bharti, I Barbaric et al
23 April 2025
Watch
Harnessing AI and omics for next-generation gene therapy manufacturing

Harnessing AI and omics for next-generation gene therapy manufacturing

Richard Braatz, Irene Rombel
14 April 2025
Interview
Navigating analytical and regulatory hurdles in early-phase clinical cell therapy development

Navigating analytical and regulatory hurdles in early-phase clinical cell therapy development

Vaibhav Patel
10 April 2025
Interview
The reality of automation  in CGT—Why closed systems matter: INFOGRAPHIC

The reality of automation in CGT—Why closed systems matter: INFOGRAPHIC

09 April 2025
Infographic
CAR-T manufacturing intensification: the next wave of CAR-T commercialization

CAR-T manufacturing intensification: the next wave of CAR-T commercialization

A Bersenev, E Kleiren, J Knighton et al
03 April 2025
Innovator Insight